REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/08/2025
Voltar para busca
Dado oficial do USPTO
GENSCRIPT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
26/08/2025
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
04/01/2019
Data de registro
25/08/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/08/2020
Última transação
26/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
CN
Examinador
GAYNOR, BARBARA
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Nanjing Genscript Biotech Co. Ltd.
Nanjing GenScript Biotech Co., Ltd.
Nanjingjinsirui Science & Technology Biology Corp.
Representantes
Yue (Robert) Xu APEX ATTORNEYS AT LAW, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Enzyme preparations for use in the foodanimal feeds and brewing industry; enzymes for industrial purposes; protein in raw material form for scientific and medical research; chemicals for use in industry; biochemical catalysts; diagnostic preparations other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; bacterial preparationsother than for medical and veterinary use; cultures of microorganisms other than for medical or veterinary use; electrophoresis gels other than for medical or veterinary purposes; enzymes for use in the food industry; enzymes for the brewing industry; proteins for the food industry; vitamins for manufacturing use
Classe 5
Cultures of microorganisms for medical or veterinary use; bacterial preparations for medical and veterinary use; chemical reagents for medical or veterinary purposes; diastase for medical purposes; enzyme preparations for medical purposes; diagnostic preparations for medical purposes; nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of multiple myelomablood cancer and solid tumor; chemical preparations for pharmaceutical or medical purposesfor treating multiple myelomablood cancer and solid tumor; enzyme dietary supplements; enzyme preparations for veterinary purposes; biological preparations for the treatment of multiple myelomablood tumor and solid tumor
Classe 9
Recorded and downloadable computer application software for mobile phonessoftware for use in database management and electronic storage of data; scientific instrumentsmagnetic separation racks that use magnetic beads and particles to purifyisolateseparate biological molecules; computer-controlled apparatus for testing and measuring magnetic beadsnot for medical purposes; diagnostic apparatus that uses magnetic beads and particles to purifyisolateseparate biological moleculesfor laboratory or research use; DNA chips; surveying instruments; bioreactors for laboratory use; chromatography apparatus for laboratory use; magnetic separators for scientific use
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
29/06/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/02/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/01/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
16/12/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
15/12/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
25/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2020
PUBO
PUBLISHED FOR OPPOSITION
09/06/2020
GPNX
NOTIFICATION PROCESSED BY IB
05/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/05/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/03/2020
GNRT
NON-FINAL ACTION E-MAILED
11/03/2020
CNRT
NON-FINAL ACTION WRITTEN
11/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2020
ALIE
ASSIGNED TO LIE
18/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2020
RFNT
REFUSAL PROCESSED BY IB
30/08/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/08/2019
RFRR
REFUSAL PROCESSED BY MPU
12/08/2019
MAFR
APPLICATION FILING RECEIPT MAILED
23/07/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/07/2019
CNRT
NON-FINAL ACTION WRITTEN
19/07/2019
DOCK
ASSIGNED TO EXAMINER
19/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/07/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/07/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENSCRIPT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.